Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros











Intervalo de año de publicación
1.
Bioengineering (Basel) ; 8(11)2021 Oct 26.
Artículo en Inglés | MEDLINE | ID: mdl-34821724

RESUMEN

Exosomes are the master transporters of genes, RNAs, microRNAs, proteins, and lipids. They have applications in major diseases, including cancer, cardiovascular diseases, neurological disorders, and diabetes mellitus. Delivery of the exosomes to recipient cells is governed by the functional heterogenicity of the tissues. Engineered exosomes are promising tools in tissue regeneration. In addition to their role as intracellular communication cargos, exosomes are increasingly primed as standard biomarkers in the progression of diseases, thereby solving the diagnostic dilemma. Futuristic empowerment of exosomes with OMICS strategy can undoubtedly be a bio-tool in translational medicine. This review discusses the advent transformation of exosomes in regenerative medicine and limitations that are caveats to broader applications in clinical use.

2.
Artículo en Inglés | WPRIM (Pacífico Occidental) | ID: wpr-23490

RESUMEN

Osteoporosis is a bone pathology leading to increased fracture risk and challenging the quality of life. The aim of this study was to evaluate the effect of an anthraquinone glycoside, aloin, on osteogenic induction of MC3T3-E1 cells. Aloin increased alkaline phosphatase (ALP) activity, an early differentiation marker of osteoblasts. Aloin also increased the ALP activity in adult human adipose-derived stem cells (hADSC), indicating that the action of aloin was not cell-type specific. Alizarin red S staining revealed a significant amount of calcium deposition in cells treated with aloin. Aloin enhanced the expression of osteoblast differentiation genes, Bmp-2, Runx2 and collagen 1a, in a dose-dependent manner. Western blot analysis revealed that noggin and inhibitors of p38 MAPK and SAPK/JNK signals attenuated aloin-promoted expressions of Bmp-2 and Runx2 proteins. siRNA mediated blocking of Wnt-5a signaling pathway also annulled the influence of aloin, indicating Wnt-5a dependent activity. Inhibition of the different signal pathways abrogated the influence of aloin on ALP activity, confirming that aloin induced MC3T3-E1 cells into osteoblasts through MAPK mediated Wnt and Bmp signaling pathway.


Asunto(s)
Adulto , Humanos , Fosfatasa Alcalina , Western Blotting , Calcio , Colágeno , Subunidad alfa 1 del Factor de Unión al Sitio Principal , Osteoblastos , Osteoporosis , Proteínas Quinasas p38 Activadas por Mitógenos , Patología , Calidad de Vida , ARN Interferente Pequeño , Transducción de Señal , Células Madre
3.
Phytomedicine ; 17(1): 42-6, 2010 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-19640694

RESUMEN

Urokinase plasminogen activator (uPA) system, comprising of uPA, its receptor uPAR and inhibitor, type 1 plasminogen activator inhibitor (PAI-1), plays a vital role in various biological processes involving extracellular proteolysis, fibrinolysis, cell migration and proliferation. The timely occurence of these processes are essential for normal wound healing. This study examines the regulation of uPA and PAI-1 by a natural polyphenol-rich compound, grape seed extract (GSE). GSE is reported to have beneficial effects in promoting wound healing. Fibroblast cells exposed to different doses of GSE for 18hours were processed for further studies such as ELISA, RT-PCR, western blotting, fibrinolytic assay, cell surface plasmin activity assay and in vitro wound healing assay. GSE treatment caused a significant downregulation of uPA and PAI-1 expression, both at the RNA and protein levels. ELISA also revealed a dose-dependent decrease in uPA and PAI-1 activities. Functional significance of the downregulation was evident in decreased fibrinolytic activity, concomittant with decreased cell-surface plasmin activity. In vitro wound healing studies showed that GSE also retarded the migration of cells towards the wounded region.


Asunto(s)
Antioxidantes/farmacología , Fibroblastos/efectos de los fármacos , Extracto de Semillas de Uva/farmacología , Inhibidor 1 de Activador Plasminogénico/metabolismo , Proantocianidinas/farmacología , Activador de Plasminógeno de Tipo Uroquinasa/metabolismo , Cicatrización de Heridas/efectos de los fármacos , Técnicas de Cultivo de Célula , Movimiento Celular/efectos de los fármacos , Supervivencia Celular/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Regulación hacia Abajo , Ensayo de Inmunoadsorción Enzimática , Fibrinolisina/metabolismo , Fibrinólisis/efectos de los fármacos , Fibroblastos/metabolismo , Flavonoides/farmacología , Humanos , Fenoles/farmacología , Inhibidor 1 de Activador Plasminogénico/genética , Polifenoles , ARN Mensajero/metabolismo , Semillas , Activador de Plasminógeno de Tipo Uroquinasa/genética , Vitis/química
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA